MediWound (MDWD) Liabilities and Shareholders Equity (2016 - 2025)

MediWound's Liabilities and Shareholders Equity history runs 10 years deep, the most recent figure standing at $86.3 million for Q4 2025.

• On a quarterly basis, Liabilities and Shareholders Equity rose 17.36% year-over-year to $86.3 million in Q4 2025; TTM through Dec 2025 was $316.7 million, a 18.21% increase from a year earlier, with the FY2025 full-year figure at $86.3 million, up 17.36% from the prior year.
• Liabilities and Shareholders Equity eased to $86.3 million in Q4 2025 per MDWD's latest filing, from $94.4 million in the prior quarter.
• Across five years, Liabilities and Shareholders Equity topped out at $94.4 million in Q3 2025 and bottomed at $19.7 million in Q4 2021.
• The 5-year median for Liabilities and Shareholders Equity is $63.4 million (2023), against an average of $53.8 million.
• Across the five-year window, Liabilities and Shareholders Equity sank 36.45% in 2021 and jumped 204.97% in 2023, its largest moves.
• Year by year, Liabilities and Shareholders Equity stood at $19.7 million in 2021, then jumped by 153.32% to $50.0 million in 2022, then soared by 32.88% to $66.5 million in 2023, then climbed by 10.59% to $73.5 million in 2024, then rose by 17.36% to $86.3 million in 2025.
• Per Business Quant, the three latest MDWD Liabilities and Shareholders Equity figures stand at $86.3 million (Q4 2025), $94.4 million (Q3 2025), and $67.0 million (Q2 2025).